Home › Meningioma › Ohio › Columbus
Meningioma clinical trials in Columbus, OH
6 studies for Meningioma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- Mount Carmel Health Center West, Columbus
- and 6 more
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPhase 2
- The Ohio State University College of Medicine (OSUCOM), Columbus
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
RecruitingPhase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RecruitingPhase 1/2
- Nationwide Children's Hospital, Columbus
Cognitive Status After Removal of Skull Base Meningioma
RecruitingObservational study
- Ohio State University Wexner Medical Center, Columbus
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Ohio State University, Columbus
Meningioma trials in other cities
- New York City, NY8 studies
- Miami, FL7 studies
- Boston, MA6 studies
- San Francisco, CA5 studies
- San Diego, CA5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Phoenix, AZ4 studies
- Arlington, VA4 studies
- Houston, TX4 studies
- Detroit, MI4 studies
- Durham, NC3 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.